On 13 September 2018, the Antimonopoly Committee of Ukraine addressed the MOH with a recommendation on approval of legal act(s) with straightforward, transparent and non-discriminative rules to:  

- prevent distortion of competition due to the use of marketing instruments within wholesale and retail sale of pharmaceuticals  

- provide end-users of pharmaceuticals with the possibility of an independent choice of pharmaceuticals in pharmacies  

- prevent sale of pharmaceuticals primarily at increased cost due the use of marketing instruments  

The development of the above-mentioned legal act by the MOH should provide market participants with clear guidance from the regulator on appropriate marketing practices. We will monitor the preparation of this legal act by the MOH and keep you updated in our newsletter.